Author: admin

  • Derek Thomas – 2016 Parliamentary Question to the Department of Health

    Derek Thomas – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Derek Thomas on 2016-02-09.

    To ask the Secretary of State for Health, what steps he is taking to measure (a) national and (b) local performance on tackling high levels of cholesterol.

    Jane Ellison

    Cholesterol testing in primary care is included in the Quality Outcomes Framework for people diagnosed with hypertension and diabetes and this is published every year by the Health and Social Care Information Centre. Public Health England’s (PHE) healthier lives website provides local comparisons of how well cholesterol is being controlled in people with diabetes. The link is below:

    http://healthierlives.phe.org.uk/topic/diabetes

    The Health Survey for England, an annual survey of the general population, has included measurements of total cholesterol and high-density lipoprotein cholesterol every year since 2008. The data is publically available from the UK Data Service.

    In addition, the National Cardiovascular Health Intelligence Network within PHE is working closely with organisations concerned with cardiovascular disease to take forward the recommendations in the recent Heart UK report ‘Helping Us to Beat Cholesterol’. This report focusses on the importance of data in the prevention and management of cardiovascular disease.

  • Derek Thomas – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    Derek Thomas – 2016 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Derek Thomas on 2016-02-09.

    To ask the Secretary of State for Business, Innovation and Skills, what assessment he has made of the implications for his policies of the report by the Social Market Foundation on the effect of single parents of a relaxation of Sunday trading hours.

    Anna Soubry

    In formulating its final proposals, the Government has carefully considered all the evidence submitted during the consultation process.

  • Chris White – 2016 Parliamentary Question to the HM Treasury

    Chris White – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Chris White on 2016-02-09.

    To ask Mr Chancellor of the Exchequer, how many businesses accessed the Seed Enterprise Investment Scheme (SEIS) in 2014-15; what the cost of SEIS was to his Department in that year; and what the return on investment was for the economy as a result of the SEIS.

    Mr David Gauke

    The Seed Enterprise Investment Scheme (SEIS) is forecast to cost the Exchequer £180m in 2014-15. Outturn figures for 2014-15 are not yet available. Updated figures on the cost of the relief will be published in December 2016.

    The first official statistics on the number of companies raising funds, number of subscriptions, and amounts raised for Seed Enterprise Investment Schemes for 2014-15 will be published in April 2016.

    No results have been published on the return on investment from the SEIS.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-02-09.

    To ask Her Majesty’s Government what procurement process was followed to commission Bain and Company to support the vanguard programme in NHS England in deciding how to invest transformation funds; what is the value of that consultancy contract; and how value for money in that contract was established.

    Lord Prior of Brampton

    The Healthcare Financial Management Association (HFMA) commissioned Bain and Company to support vanguards as an extension to work previously commissioned from the company as part of a programme called Future Focused Finance, an initiative sponsored by the Department of Health and arm’s length bodies. This earlier work for the HFMA had focused on the design of a value-based decision effectiveness tool, piloted in Mid-Cheshire and Liverpool. The HFMA, in partnership with NHS England, commissioned the extension to this work so that the tool could be used to support value-based decision-making in the 2016-17 New Care Models programme.

    Alternatives were not sought from competitors because the vanguard support built on the original Bain and Company work for the HFMA.

    The value of the vanguard support contract is £650,000. Value for money was obtained by negotiation, having been benchmarked with other commissions made by the National Health Service to external health consultancies.

    As part of the contract, Bain and Company will be handing over its approach to NHS England, so that NHS England can support other areas in implementing new care models.

    Bain and Company has not been commissioned to assess evidence to support transformation and potential for replication of new care models in other areas. The company is commissioned to develop and implement a framework that appropriately experienced NHS staff can use to assess such evidence. Intellectual property rights in respect of the framework in the future are assigned to HFMA under the terms of the contract. The NHS is entitled to use the framework free of charge in perpetuity.

    Bain and Company is involved in the development of the tool used to make the assessment, and in the implementation of the process to use that tool. The company is specifically commissioned to help vanguard sites to use the tool and to summarise the resulting value propositions to facilitate decision-making by NHS England.

    No conflict of interest arises as decisions concerning funding allocations for individual vanguards are made by NHS England’s Executive Team and Investment Committee and not Bain and Company.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-02-09.

    To ask Her Majesty’s Government what assessment they have made of the experience that Bain and Company has to assess evidence to support transformation and potential for replication in terms of health services in the NHS context.

    Lord Prior of Brampton

    The Healthcare Financial Management Association (HFMA) commissioned Bain and Company to support vanguards as an extension to work previously commissioned from the company as part of a programme called Future Focused Finance, an initiative sponsored by the Department of Health and arm’s length bodies. This earlier work for the HFMA had focused on the design of a value-based decision effectiveness tool, piloted in Mid-Cheshire and Liverpool. The HFMA, in partnership with NHS England, commissioned the extension to this work so that the tool could be used to support value-based decision-making in the 2016-17 New Care Models programme.

    Alternatives were not sought from competitors because the vanguard support built on the original Bain and Company work for the HFMA.

    The value of the vanguard support contract is £650,000. Value for money was obtained by negotiation, having been benchmarked with other commissions made by the National Health Service to external health consultancies.

    As part of the contract, Bain and Company will be handing over its approach to NHS England, so that NHS England can support other areas in implementing new care models.

    Bain and Company has not been commissioned to assess evidence to support transformation and potential for replication of new care models in other areas. The company is commissioned to develop and implement a framework that appropriately experienced NHS staff can use to assess such evidence. Intellectual property rights in respect of the framework in the future are assigned to HFMA under the terms of the contract. The NHS is entitled to use the framework free of charge in perpetuity.

    Bain and Company is involved in the development of the tool used to make the assessment, and in the implementation of the process to use that tool. The company is specifically commissioned to help vanguard sites to use the tool and to summarise the resulting value propositions to facilitate decision-making by NHS England.

    No conflict of interest arises as decisions concerning funding allocations for individual vanguards are made by NHS England’s Executive Team and Investment Committee and not Bain and Company.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-02-09.

    To ask Her Majesty’s Government how NHS England are ensuring that there is no conflict in how Bain and Company supports both vanguards in their application for funds, and NHS England in deciding how to allocate funds.

    Lord Prior of Brampton

    The Healthcare Financial Management Association (HFMA) commissioned Bain and Company to support vanguards as an extension to work previously commissioned from the company as part of a programme called Future Focused Finance, an initiative sponsored by the Department of Health and arm’s length bodies. This earlier work for the HFMA had focused on the design of a value-based decision effectiveness tool, piloted in Mid-Cheshire and Liverpool. The HFMA, in partnership with NHS England, commissioned the extension to this work so that the tool could be used to support value-based decision-making in the 2016-17 New Care Models programme.

    Alternatives were not sought from competitors because the vanguard support built on the original Bain and Company work for the HFMA.

    The value of the vanguard support contract is £650,000. Value for money was obtained by negotiation, having been benchmarked with other commissions made by the National Health Service to external health consultancies.

    As part of the contract, Bain and Company will be handing over its approach to NHS England, so that NHS England can support other areas in implementing new care models.

    Bain and Company has not been commissioned to assess evidence to support transformation and potential for replication of new care models in other areas. The company is commissioned to develop and implement a framework that appropriately experienced NHS staff can use to assess such evidence. Intellectual property rights in respect of the framework in the future are assigned to HFMA under the terms of the contract. The NHS is entitled to use the framework free of charge in perpetuity.

    Bain and Company is involved in the development of the tool used to make the assessment, and in the implementation of the process to use that tool. The company is specifically commissioned to help vanguard sites to use the tool and to summarise the resulting value propositions to facilitate decision-making by NHS England.

    No conflict of interest arises as decisions concerning funding allocations for individual vanguards are made by NHS England’s Executive Team and Investment Committee and not Bain and Company.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-02-09.

    To ask Her Majesty’s Government what estimate they made of the costs of closing NHS Direct at the time of the decision, and what was the actual cost of closing NHS Direct.

    Lord Prior of Brampton

    NHS Direct NHS Trust’s Final Report and Accounts, published in June 2014, set out decommissioning costs of £69.2 million for 2012/13. The Trust’s business case, submitted for approval of the transaction for its dissolution which took effect on 1 April 2014, included an estimated cost of closure of £36.3 million in 2014/15. The Final Report and Accounts showed the decommissioning costs for this year to be £17.6 million.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-02-09.

    To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 27 January (HL5180), how they will ensure that the forecast increase in the level of podiatry commissions by 2020 will be met by the podiatry workforce; and what assessment they have made of the risks presented by the reduction in Health Education England commissioned student places in 2016–17 and the end of bursaries in August 2017.

    Lord Prior of Brampton

    Health Education England (HEE) operates an annual comprehensive planning process to ensure their investments meet the future needs of the population. This process determines the education commissioning volumes for the following financial year.

    The HEE Commissioning and Investment Plan – 2016/17 includes a forecast increase in the available supply of podiatrists into the National Health Service workforce of 36.4% by 2020. The forecast reflects the planned commissions but also the net effect of different levels of non-retirement, leavers and joiners other than from HEE training programmes.

    HEE local teams are responsible for assessing the forecast supply and demand. The activity of gathering evidence, modelling and decision making at the local level is supported by Partnership Councils, including NHS and non-NHS service providers.

    The Department will run a consultation on how the funding reforms for nursing, midwifery and allied health education can be most successfully implemented. We currently expect to consult during March 2016. As part of this, an economic impact assessment and equality impact assessment will be published.

    HEE will continue to have a central role in the commissioning of nursing, midwifery and allied health courses which will include podiatry. They will continue to provide sufficient clinical placement funding for those places needed to meet the workforce planning needs of the NHS.

    We estimate that the reforms will allow universities to be able to offer up to 10,000 more nursing, midwifery and allied health training places over this parliament.

  • Lord Lexden – 2016 Parliamentary Question to the Northern Ireland Office

    Lord Lexden – 2016 Parliamentary Question to the Northern Ireland Office

    The below Parliamentary question was asked by Lord Lexden on 2016-02-09.

    To ask Her Majesty’s Government what is the total sum to date that has been paid in compensation to persons found guilty of terrorist-related offences in Northern Ireland whose convictions have been overturned because the activities of British agents were not disclosed to the courts; how many further such claims for compensation are pending; and whether compensation will be paid if more claims are made.

    Lord Dunlop

    It is long standing policy of successive Governments neither to confirm nor deny the involvement of agents of the Security and Intelligence Agencies in any specific activity in order to protect the UK’s national security. I am therefore unable to comment further.

    However, where national security sensitive information is relevant to an application for compensation for a miscarriage of justice in Northern Ireland, for example where the Court of Appeal is unable to make public its full reasons for quashing the conviction, the decision on whether compensation is payable is one for the Secretary of State for Northern Ireland. In making that decision, she will apply the new test set out in section 133(1Z) of the Criminal Justice Act 1988, namely that compensation is payable “if and only if the new or newly discovered fact shows beyond reasonable doubt that the person did not commit the offence”.

  • Lord Lexden – 2016 Parliamentary Question to the Northern Ireland Office

    Lord Lexden – 2016 Parliamentary Question to the Northern Ireland Office

    The below Parliamentary question was asked by Lord Lexden on 2016-02-09.

    To ask Her Majesty’s Government how many claims for compensation by the victims of terrorism in Northern Ireland remain outstanding.

    Lord Dunlop

    Matters relating to policing and justice were devolved to the Northern Ireland Executive in 2010 by the Northern Ireland (Devolution of Policing and Justice Functions Order) 2010. As a consequence, responsibility for compensation of the victims of terrorism in Northern Ireland now rests with the Northern Ireland Executive, and in particular the Department of Justice for Northern Ireland (DOJNI), which oversees the Criminal Injuries Compensation Scheme.